No, Sri Lanka Will not Lose Free Vaccines Over the World Bank’s Upper-Middle-Income Reclassification

Subscribe to our WhatsApp Channel

When the World Bank moved Sri Lanka into the upper-middle-income bracket in July 2026, a milestone of economic recovery quickly turned into a public health scare. A Lankadeepa newspaper headline, echoed across televised newspaper-review programmes, told the country it would now be cut off from “free vaccines,” and within hours anxious parents were sharing the warning across Facebook. The posts conflated two entirely separate things: the World Bank’s income classification and the vaccine support Sri Lanka receives. Here are the posts that carried the claim.

Social Media Posts

A report published in the Lankadeepa newspaper on 7 September 2026 triggered these posts, and its repetition in newspaper-review segments pushed them further.

Fact-Check

These posts rested almost entirely on the Lankadeepa report. The facts behind each of its claims are set out below.

Free vaccines come from the Gavi Vaccine Alliance, not the World Bank

The World Bank lends money and provides development financing, but it does not distribute free vaccines to national immunization programmes. Lower-income countries receive vaccine support and free doses through Gavi, the Vaccine Alliance.

The World Health Organization, UNICEF, and the Bill & Melinda Gates Foundation, alongside the World Bank, are all partners of Gavi. The World Bank also serves as treasury manager for the International Finance Facility for Immunization (IFFIm), which raises funds on Gavi’s behalf. The claim that the World Bank itself hands out “free vaccines” is therefore false and misleading.

Sri Lanka has self-financed its routine vaccines since 1995

Every core EPI vaccine under Sri Lanka’s National Immunization Programme has been fully purchased with domestic government funds since 1995, and the Ministry of Health keeps a dedicated budget line for the purpose. Supporting detail is available here and here.

Between 2002 and 2016, Gavi support to Sri Lanka never covered core vaccines. It covered only the initial cost of introducing new vaccines : hepatitis B (2002), pentavalent (2008), IPV (2015) and, as a special project, HPV (2017).

Sri Lanka was in fact among the first countries in Asia to formally graduate from Gavi support in 2016.

Sri Lanka graduated from Gavi support in 2016, long before the 2026 reclassification

A country’s Gross National Income (GNI) per capita is the main factor that decides its eligibility for Gavi’s financial and vaccine support. Gavi first began supporting Sri Lanka in 2002.

Gavi set its eligibility threshold at a GNI per capita above US$1,500 in 2009. Because Sri Lanka had already crossed it, the country entered the graduation phase that year. It then moved through a 2010–2015 transition period, during which Gavi support was gradually reduced as domestic financing rose before Sri Lanka officially and fully graduated in early 2016.

Gavi’s current (2026) eligibility threshold is around US$2,300, while Sri Lanka’s GNI per capita is roughly US$4,670, about double the ceiling. Sri Lanka crossed the Gavi threshold some 17 years ago. No vaccines were newly withdrawn or altered for the country because of any World Bank income classification in 2026.

Gavi and UNICEF stepped in only as temporary humanitarian help during the economic crisis

During the severe dollar shortage and economic crisis of recent years, Gavi and UNICEF temporarily resumed vaccine supply between 2023 and 2025 as special humanitarian assistance to head off a shortage. Further detail is here and here.

Although Sri Lanka had left Gavi’s regular support in 2016, the crisis produced shortages of medicines and foreign currency. In response, Gavi opened a time-limited package under its “Middle-Income Countries Fragility Approach,” contributing funding to procure the essential vaccines given to Sri Lankan infants and schoolchildren from the crisis year of 2023.

Current status: self-financing has resumed, with new vaccines planned

During an April 2025 visit, Gavi representatives met the Ministry of Health and agreed to provide technical assistance and concessional support for future new vaccines, including the pneumococcal conjugate vaccine (PCV) and the rotavirus vaccine.

Gavi’s support did not “end after COVID.” What ended was the timeframe of the temporary emergency financing provided because of the economic crisis. As the economy stabilized, the government resumed self-financing its vaccines through the domestic budget, as it had before. Contrary to the newspaper’s implication, Sri Lanka is not a country “dependent on free vaccine handouts.” What is happening is simply the close of temporary crisis relief and a return to the normal self-financing process.

The World Bank’s income classification has no link to vaccine support

Therefore, premise of the Lankadeepa report, that Sri Lanka would “lose World Bank or Gavi support in 2027/2028”, is false and misleading. There is no connection between the World Bank’s income classification and vaccine support.

The World Bank’s reclassification of Sri Lanka as an upper-middle-income country, effective 1 July 2026, mainly affects the interest rates and financial terms on future loans. We explained this reclassification and its implications in an earlier article: Sri Lanka’s designation as an upper-middle-income country versus the ground-level economic hardship — a clarification.

Gavi’s threshold for vaccine-assistance eligibility, based on GNI per capita, sits at a comparatively low level. Even when Sri Lanka was in the lower-middle-income category, it remained well above that threshold, so the 2026 classification has no bearing on the country’s vaccine eligibility.

The World Bank has never handed out free vaccines

In April 2021, the World Bank provided an additional US$80.5 million in financing to help Sri Lanka procure and distribute COVID-19 vaccines. That was a repayable loan facility, not a gift. The doses Sri Lanka genuinely received free of charge during the pandemic — over 1.5 million of them — came as humanitarian donations through the COVAX Facility, co-led by Gavi. The report created a misleading premise by conflating the World Bank’s general lending conditions with Gavi’s separate vaccine-eligibility policies.

What the World Bank told Fact Crescendo

In reply to our email inquiry, a representative of the World Bank’s Communications team provided the following attributable statement:

“The front-page headline of this article is factually incorrect. The World Bank does not provide free vaccines to Sri Lanka. Vaccine support has been provided by Gavi, the Vaccine Alliance, an independent organization with its own eligibility criteria. The World Bank’s income classification of Sri Lanka is a separate statistical exercise and does not determine Gavi’s support decisions. Lankadeepa issued a correction on this matter today (10), and we welcome further questions from media seeking to report this accurately.”

The World Bank added that while it approved project financing for Sri Lanka’s COVID-19 vaccination programme in 2021, strengthening government systems such as cold-chain capacity and health logistics, it did not at any point purchase or supply vaccines directly. As treasury manager for the International Finance Facility for Immunization (IFFIm), it plays a financial role only; as a Gavi partner it holds no authority over which countries Gavi supports, or on what terms.

It also noted that the Lankadeepa report had left out critical context: the Ministry of Health runs one of the strongest national immunization programmes in the region, with consistently high coverage, and that programme has been largely self-financed from domestic funds since well before the reclassification, specifically, since 2016.

The representative further stated that the Sri Lankan Cabinet has already approved the Ministry of Health’s plan to procure the vaccines needed for the National Immunization Programme through UNICEF’s Global Supply Division for 2026–2030. This will let the country secure a continuous supply of WHO-prequalified vaccines at competitive, concessional prices, and reflects the Ministry’s forward planning and institutional capacity. The World Bank advised directing questions about the future of Sri Lanka’s vaccination programme to Gavi and the Ministry of Health.

What Health Minister Nalinda Jayatissa told us

We asked the Minister whether Sri Lanka currently holds any agreement with Gavi for vaccine procurement. He said that although discussions were held with Gavi in late 2025, no procurement agreement has been signed.

He explained that the required vaccines are bought through UNICEF’s Global Supply Division: The Ministry of Health provides the funds to the State Pharmaceuticals Corporation of Sri Lanka (SPC), which then transfers payment to UNICEF’s Global Supply Division to procure the vaccines. Sri Lanka is therefore not dependent on free vaccines; it fully funds its own procurement through the government budget, with a dedicated Ministry of Health allocation for the purpose.

We have also reached out to Gavi on this matter and will update this article accordingly.

How Gavi decides who qualifies for support

Eligibility for Gavi’s financial and vaccine support is determined mainly by a country’s GNI per capita, using the World Bank’s annual data. Under Gavi’s current strategic plan, Gavi 6.0, effective from 2026, the qualifying criteria and key stages are as follows.

Basic income threshold. A country’s GNI per capita must be US$2,300 or lower. (Last year the threshold was US$1,810; from 2026 the Gavi Board raised it to US$2,300 to reduce the risk countries face while transitioning out of support.)

Initial Self-Financing Stage. For countries classified as low-income under World Bank criteria. They receive maximum support and pay only a minimal fixed contribution of around US$0.20 per dose. Particulars here, here and here.

Preparatory Transition Stage. Applies once a country’s income exceeds the World Bank’s low-income threshold but stays below Gavi’s US$2,300 ceiling. The share of vaccine costs a country co-finances rises by 15% each year.

Accelerated Transition Stage. Begins once a country’s average per-capita income over three consecutive years passes US$2,300. The government’s funding burden rises sharply, and Gavi support is phased out within eight years as the country becomes fully self-sufficient. This is the stage Sri Lanka passed through in 2016. Facts here, here and here.

Technical assessment. Even when a country meets the financial criteria, an independent expert panel including WHO and UNICEF must approve support based on the performance and planning of the national immunization programme. Specifics here and here.

Emergency and humanitarian support (Catalytic / Fragility). Even above the income threshold, Gavi provides temporary concessional funding under special exceptions for middle-income countries facing war, instability, or severe economic crises — exactly the route Sri Lanka used — to prevent the collapse of infant immunization. Details here and here.

Which countries qualify for Gavi support in 2026

Under Gavi 6.0, 54 countries worldwide meet the eligibility criteria for support in 2026, grouped into three stages by income and payment obligations.

Initial Self-Financing Stage (26 countries). Asia: Afghanistan, North Korea, Syria, Yemen. Africa and other regions: Burkina Faso, Burundi, Central African Republic, Chad, Democratic Republic of Congo, Eritrea, Ethiopia, Gambia, Guinea-Bissau, Liberia, Madagascar, Malawi, Mali, Mozambique, Niger, Rwanda, Sierra Leone, Somalia, South Sudan, Sudan, Togo, Uganda.

Preparatory Transition Stage (21 countries). Asia and Pacific: Cambodia, Kyrgyzstan, Laos, Myanmar, Nepal, Pakistan, Solomon Islands, Tajikistan, Angola, and Timor-Leste (the last two regained eligibility in 2026 after economic setbacks). Africa and Latin America: Benin, Cameroon, Comoros, Guinea, Haiti, Kenya, Lesotho, Mauritania, Nigeria, Senegal, Tanzania, Zambia, Zimbabwe.

Accelerated Transition Phase (7 countries). Bangladesh, Republic of Congo, Côte d’Ivoire, Djibouti, Ghana, Papua New Guinea, and São Tomé and Príncipe — all set to fully exit Gavi support in the coming years.

Why countries like Sri Lanka still get low prices

As the world’s largest vaccine buyer, Gavi pools demand from many low- and middle-income countries and presents that combined demand to manufacturers. Assured of large, long-term sales, manufacturers cut prices substantially, and Gavi’s intervention helped raise the number of global vaccine suppliers from 5 in 2001 to 19 in 2022.

Even after a country leaves Gavi’s support list, Gavi’s policies (1.2.3, 1.2.4, 1.2.8) prevent a sudden financial shock. Graduated countries such as Sri Lanka keep the right to buy vaccines through UNICEF procurement services at the lowest Gavi-negotiated prices under multi-year supplier commitments, along with technical assistance and flexible funding to introduce costly new vaccines such as pneumococcal ones. So, although Sri Lanka exited Gavi support in 2016, the Ministry of Health can still buy quality vaccines at heavily subsidized prices far below open-market rates.

What Lankadeepa published, and how it changed

Lankadeepa removed its 9 September article headlined “No Free Vaccines for Sri Lanka from the World Bank” and republished it as “Sri Lanka May Not Receive Free Vaccines Due to Its Classification as a Middle-Income Country.” The revised report still framed the information misleadingly. Archived report  |  Web Archive On 10 September the paper published a further report, “Is Sri Lanka an Upper-Middle-Income Country?” Read here.

Join Us

Join us to learn more about our fact-check investigations.

Facebook  |  Twitter  |  Instagram  |  Google News  |  TikTok  |  YouTube

Conclusion

The viral claim is false. The World Bank is not a vaccine grant agency: even during the COVID-19 pandemic, its help to Sri Lanka came as repayable financing, while the genuinely free doses arrived through the Gavi-co-led COVAX Facility. Sri Lanka graduated from Gavi support back in 2016, after its GNI per capita crossed the eligibility threshold, and it has fully funded the core vaccines of its National Immunization Programme from the domestic budget since 1995.

The World Bank’s July 2026 reclassification of Sri Lanka as upper-middle-income affects the country’s international borrowing terms, not its access to vaccines. The World Bank Communications team, Health Minister Nalinda Jayatissa, and Gavi’s own eligibility documentation all confirm that income classification and vaccine support are separate systems, and that Sri Lanka’s immunization programme continues uninterrupted through UNICEF’s Global Supply Division for 2026–2030.

Linking the World Bank’s economic reclassification to a supposed loss of free vaccines is therefore misleading.